Kristina Bennet Emdal

Kristina Bennet Emdal

Assistant Professor, Special Consultant

Member of:

    ORCID: 0000-0002-9789-0665

    Publication year:
    All
    11 - 15 out of 15Page size: 10
    1. 2017
    2. Published

      Combinatorial Drug Screening Identifies Ewing Sarcoma–specific Sensitivities

      Radic-Sarikas, B., Tsafou, K. P., Emdal, Kristina Bennet, Papamarkou, T., Huber, K. V. M., Mutz, C., Toretsky, J. A., Bennett, K. L., Olsen, Jesper Velgaard, Brunak, S., Kovar, H. & Superti-Furga, G., Jan 2017, In: Molecular Cancer Therapeutics. 16, 1, p. 88-101 14 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. 2015
    4. Published

      Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation

      Emdal, Kristina Bennet, Pedersen, A., Bekker-Jensen, D. B., Tsafou, K. P., Horn, H., Lindner, S., Schulte, J. H., Eggert, A., Jensen, Lars Juhl, Francavilla, C. & Olsen, Jesper Velgaard, 2015, In: Science Signaling. 8, 374, ra40.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. 2013
    6. Published

      Functional Proteomics Defines the Molecular Switch Underlying FGF Receptor Trafficking and Cellular Outputs

      Francavilla, C., Rigbolt, K. T. G., Emdal, Kristina Bennet, Carraro, G., Vernet, E., Bekker-Jensen, D. B., Streicher, W., Wikström, M., Sundström, M., Bellusci, S., Cavallaro, U., Blagoev, B. & Olsen, Jesper Velgaard, 26 Sep 2013, In: Molecular Cell. 51, 6, p. 707-22 16 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. 2012
    8. Published

      NFkB signaling is important for growth of antiestrogen resistant breast cancer cells

      Yde, C. W., Emdal, Kristina Bennet, Guerra, B. & Lykkesfeldt, A. E., 2012, In: Breast Cancer Research and Treatment. 135, 1, p. 67-78 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. 2010
    10. Published

      Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance

      Sonne-Hansen, Katrine, Norrie, I. C., Emdal, Kristina Bennet, Benjaminsen, R. V., Frogne, T., Christiansen, I. J., Kirkegaard, T. & Lykkesfeldt, A. E., 2010, In: Breast Cancer Research and Treatment. 121, 3, p. 601-13 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 Next

    ID: 33521777